|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||69.03 - 70.64|
|52 Week Range||52.51 - 71.47|
|PE Ratio (TTM)||26.53|
|Earnings Date||Feb 14, 2018 - Feb 19, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||72.85|
U.S. health insurer UnitedHealth Group said it will buy a primary and urgent care unit of DaVita to bolster its primary and urgent care services. Fred Katayama reports.
DENVER , Dec. 14, 2017 /PRNewswire/ -- The following media statement is attributable to DaVita (NYSE: DVA). We take full ownership and continue to embrace transparency and rigorous compliance. DaVita is ...
DaVita Physician Solutions helps solve for the physician experience through modern technology solutions DENVER , Dec. 14, 2017 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading independent medical group ...
DENVER , Dec. 13, 2017 /PRNewswire/ -- DaVita Kidney Care , a division of DaVita Inc. (NYSE: DVA), a leading provider in kidney care services, released its "Today's Kidney Diet: Home-Cooked Holidays" ...
After a divestiture deal that could raise nearly $5 billion for kidney dialysis leader DaVita (DVA) is now 13% higher than the level where Barron's warned that insurers were attacking DaVita's profits ("Insurers Press Dialysis Claims," September 2, 2017). Bulls like John Ransom at Raymond James expect the company to repurchase stock and pay down debt with the proceeds from a December 6 deal to sell its medical practices to UnitedHealth Group (UNH). On December 7, the Raymond James analyst raised his rating on DaVita shares from Outperform to a Strong Buy, while upping his price target from $65 to $84.
The Dow endured a volatile week even as Republicans tasted success on the tax legislation front.
A.M.Best acknowledges UnitedHealth's(UNH) deleveraging strategy and earnings accretion from DaVita Medical Group acquisition.
Stock Monitor: DaVita Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 08, 2017 / Active-Investors issued a free report on UnitedHealth Group Inc. (NYSE: UNH ), which is readily accessible upon ...
UnitedHealth's (UNH) intention to buy DaVita Medical reflects its continuous effort to build up a vertically integrated business model
As CVS Health and Aetna seek to build an integrated health care company without doctors, rival UnitedHealth Group makes $4.9 billion deal to add more providers.
DaVita (DVA) soared to the top of the S&P 500 today after it sold its Medical Group for nearly $5 billion to UnitedHealth Group (UNH). DaVita gained 14% to $69.20 today, while the S&P 500 finished little changed at 2629.27. UnitedHealth dipped 0.1% to $219.94.
UnitedHealth announced Wednesday that it would by dialysis center DaVita's medical unit for $4.9 billion in cash.
On Wednesday, only a few days after the CVS (CVS) and Aetna (AET) deal helped shine a light on the quickly changing healthcare industry, UnitedHealth Group (UNH) announced that it will buy a unit of DaVita Inc. (DVA) for nearly $5 billion.
Among the companies with shares expected to trade actively in Wednesday's session are Apple, Alphabet, Home Depot, DaVita and Walgreens Boots Alliance.
Stocks were poised for a lower open Wednesday, following third-quarter productivity data and a surge in bitcoin past $12,000, which now makes it bigger than all but 16 S&P 500 components. S&P 500 futures were down 0.1% ahead of the open. The Dow Jones Industrial Average futures and Nasdaq futures were both off 0.3%.
Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:25 a.m. ET.
UnitedHealth has struck a $4.9 billion deal to acquire the DaVita Medical unit of kidney dialysis firm DaVita in an all-cash transaction.